Search for a trial

Prospective, randomized, open label trial of six vs. twelve months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction.

To test the hypothesis that 6 months DAPT after second generation DES implantation in STEMI is not inferior to 12 months DAPT in terms of clinical outcomes (composite endpoint of all-cause mortality, any MI, any revascularization, stroke and major…

SECOND GENERATION DRUG ELUTING STENTS IMPLANTATION FOLLOWED BY SIX VERSUS TWELVE MONTH DUAL ANTIPLATELET THERAPY.

To test the non-inferiority of 6- versus 12- month dual antiplatelet therapy in patients with lesions treated with at least one second generation DES.

PE-Prove Study
PROMUS* Element* Everolimus-Eluting Coronary Stent System
European Post-Approval Surveillance Study
A prospective, open label, multi-center observational study

Please see pages 3-5 of the Protocol

Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MiStent SES) for Revascularization of Coronary Arteries, the DESSOLVE III Study

This protocol will provide data to comply with regulatory requirements as well as gain substantial additional information on patients in a real world setting. This protocol will compare clinical outcomes of the MISTENT and XIENCE in a broad patient…

A prospective multicenter randomized post market all-comer trial to assess the safety and effectiveness of the SUPRAFLEX sirolimus-eluting coronary stent system for the treatment of atherosclerotic lesion(s).

This protocol will compare clinical outcomes of the SUPRAFLEX and XIENCE drug-eluting stents in a broad patient and lesion population and will gain substantial additional information on patients in a real world setting. These data will also provide…

Target All Comer: A prospective multicenter randomized post market trial to assess the safety and effectiveness of the Firehawk* rapamycin target eluting cobalt chromium coronary stent system (Firehawk* stent system) for the treatment of atherosclerotic lesion(s)

This scientific study is intended to compare the safety and effectiveness of two stents, the Firehawk* stent and the XIENCE* stent. Both stents release a medicine. This reduces the odds of the blood vessel narrowing again. The Firehawk* stent is…